Enzo Targets Siemens Over Viral Load Testing Patent

Law360, New York (April 20, 2012, 7:51 PM EDT) -- Enzo Life Sciences Inc. launched a suit in Delaware federal court Friday accusing in vitro diagnostics company Siemens Healthcare Diagnostics Inc. of infringing its patent covering HIV and hepatitis viral load monitoring technology.

The biotech company claims Siemens, either by itself or in conjunction with others, has infringed U.S. Patent Number 7,064,197 by making and selling certain nucleic acid array products based on bDNA technology.

Such products include Versant HIV-1 RNA (bDNA), Versant HCV RNA 3.0 Assay (bDNA) and Versant HBV bDNA 3.0 Assay (RUO), the...
To view the full article, register now.